Since its approval in 1982 by the US FDA for nodulocystic acne, isotretinoin till date remains the gold standard drug for this indication, facing no competition from its contemporaries. Besides, isotretinoin has proven to be useful in treating a variety of other dermatoses. Further, even for treating acne, there are a number of regimens followed with isotretinoin, allowing flexibility for the same.